Similar outcomes after haploidentical transplantation with post-transplant cyclophosphamide versus HLA-matched transplantation: a meta-analysis of case-control studies
Oncotarget2017Vol. 8(38), pp. 63574–63586
Citations Over TimeTop 10% of 2017 papers
Zhenyang Gu, Li Wang, Lei Yuan, Wenrong Huang, Meng Li, Lixun Guan, Qingyi Wang, Zhe Gao, Shasha Zhao, Lan Luo, Feiyan Wang, Nan Yang, Dai‐Hong Liu, Jon C. Aster, Chunji Gao
Abstract
The results of this meta-analysis suggest that haplo-HCT with PT-Cy can achieve comparable outcomes with those of HLA-matched HCT. Haploidentical donors can be a feasible and valid alternative when conventional HLA-matched donors are unavailable.
Related Papers
- → USE OF CYCLOPHOSPHAMIDE AND ENHANCING SERUM TO SUPPRESS RENAL ALLOGRAFT REJECTION IN THE RAT(1979)13 cited
- → Pseudomonas aeruginosa Infection in Mice After Treatment With Cyclophosphamide(1975)8 cited
- → Experimental Study of Ultralow-Dose Antibodies to Cyclophosphamide on Cyclophosphamide Myelotoxicity(2009)1 cited
- → Effect of Paclitaxel on Antitumor Activity of Cyclophosphamide: Study on Two Transplanted Tumors in Mice(2015)1 cited
- Induction of apoptosis in rat thymus by cyclophosphamide(1999)